Tag Archive for: Wezlana

The Department of Health and Human Services in a court filing last week said that the blockbuster treatment could be “deselected” from the drug price negotiation list, given the recent approval of Amgen’s Stelara biosimilar.

The agency approved the drug to treat multiple inflammatory diseases.